Table 3 Univariate Cox regression between several clinical factors and recurrence after BCG therapy

From: The role of TERT C228T and KDM6A alterations and TME in NMIBC treated with BCG

Variable

Contrast level

Ref level

HR

Lower 95% CI

Upper 95% CI

P value

Stage

Ta

T1

0.354

0.047

2.66

0.313

Stage

Tis

T1

4.99

0.611

40.8

0.134

Gender

Male

Female

1.37

0.399

4.7

0.617

Age

  

1

0.955

1.06

0.866

Tumor percent

  

0.989

0.969

1.01

0.312

TMB

  

0.96

0.889

1.04

0.304

  1. BCG bacillus Calmette-Guérin, Ref reference, HR hazard ratio, CI confidence interval, TMB tumor mutation burden.
Back to article page